ArticleMolecular and clinical oncology2021

Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low-intermediate risk.

Jingjing Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.